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Endothelial progenitor cells (EPCs) are thought to originate from the bone mar-row, mobilize in response to ischemia, and home to sites of vascular injury. Despite uncertainty regarding their origin, phenotype, and therapeutic viability, 
there remains great interest in harnessing EPCs to promote vascular regeneration. 
Autologous bone marrow cells have been delivered to thousands of patients, on the 
premise that these populations contain functional EPCs, with conflicting results.1 
One potential explanation for the lack of consistent benefit is that bone marrow is 
not the origin of circulating EPCs. Indeed, although late-outgrowth endothelial cells 
can be readily isolated from cord and peripheral blood,2,3 we have not been able to 
obtain endothelial cells from the culture of bone marrow.3 These findings suggest 
that circulating EPCs arise from an alternative niche in the vessel wall.
To define EPC origin, we recruited 5 male participants (46±7 years) who had 
undergone allogeneic bone marrow transplant from female donors for the treat-
ment of hematological malignancy 12 to 120 months previously. The study was 
performed with approval from our research ethics committee and with written in-
formed consent. Complete donor chimerism was demonstrated in all participants 
at the time of enrollment. Early- and late-outgrowth endothelial cells were isolated 
from whole blood,2,3 and vessel wall endothelial cells were harvested from forearm 
veins using a J-shaped guidewire and expanded in culture. The contribution of bone 
marrow cells to each lineage was assessed by using fluorescence in situ hybridiza-
tion to detect the X and Y chromosomes, and supported by live cell imaging, flow 
cytometry, and immunofluorescence staining. Genotype was further analyzed by 
short tandem repeat analysis using multiplex polymerase chain reaction amplifica-
tion and detection of DNA sequences of loci that frequently contain polymorphisms. 
Clonogenic potential at the single-cell level was quantified in each lineage, and the 
origin of clonogenic progenitors was assessed by fluorescence in situ hybridization.
All early-outgrowth cells had an XX genotype consistent with bone marrow origin, 
formed clusters of spindle-shaped cells expressing high levels of the pan-leukocyte 
antigen CD45 rather than endothelial antigens, and did not undergo proliferation or 
clonogenic expansion (Figure, A and B). Therefore, early-outgrowth cells, previously 
described as endothelial cell colony-forming units, are hematopoietic and not the 
progeny of circulating EPCs. In contrast, all vessel wall endothelial cells had an XY 
genotype, confirming that they were not derived from bone marrow. These cells pro-
liferated in culture to form a cobblestone monolayer with ubiquitous expression of 
CD31. During early passages, late-outgrowth endothelial cells had a mixed genotype 
with both XX and XY cells, although the proportion of cells with an XX genotype 
decreased from 24.8±4.4% to 0.8±0.5% by the third passage (P<0.01) (Figure, B). 
It is important to note that, of those expressing CD31, 99.3±0.7% had an XY geno-
type at the third passage and therefore did not arise from bone marrow (Figure, C). 
In contrast, those that did not express CD31 had an XX genotype and were likely 
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Figure. The origin of endothelial progenitor cells. 
A, Flow cytometric analysis of early-outgrowth cells, late-outgrowth endothelial cells, and vessel wall endothelial cells with antibodies to CD45, CD31, CD34, KDR, 
and CD146. Immunofluorescence staining for viable nuclei (DRAQ5, yellow), CD45 (blue), CD146 (magenta), and CD31 (green). Scale bar: 500 µm. B, Fluores-
cence in situ hybridization (FISH) for the X and Y chromosomes combined with CD31 staining of early-outgrowth cells (day 5), late-outgrowth endothelial cells 
(passage 1), and vessel wall endothelial cells (passage 1) in male patients with sex-mismatched bone marrow transplants. Representative images show Y chromo-
some (green), X chromosome (red), CD31 (yellow), and nuclei (DAPI, blue). Examples of CD31-negative cells with an XX genotype (Continued )
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contaminating hematopoietic cells commonly found by 
using this isolation protocol (Figure, D).2 These cells ex-
pressed CD45, were observed overlying the endothelial 
monolayer in 3-dimensional confocal z-stacks (Figure, E), 
and were diminished from passage 1 to 3 (16.5±9.1% 
versus 1.8±0.9%; P<0.05), presumably because of their 
lack of proliferative capacity and inability to survive in 
endothelial-specific growth conditions.
Short tandem repeat analysis of the sex-specific 
amelogenin gene locus was consistent with fluores-
cence in situ hybridization (Figure, F), confirming the 
XX genotype of early-outgrowth cells, the XY genotype 
of vessel wall endothelial cells, and that late-outgrowth 
endothelial cells were initially of mixed genotype with 
a declining fraction of contaminating XX cells between 
passages 1 and 3 (36.3±2.2% to 5.9±3.6%, P<0.05). 
Clonogenic colonies expanded from single cells were 
only obtained for late-outgrowth endothelial cells (4/5 
participants, 8.8±4.0% efficiency) (Figure, G). All clones 
expressed CD31 and were entirely XY in genotype.
Although our study includes a small number of par-
ticipants, we have systematically studied the origin of 
EPCs in people with sex-mismatched bone marrow 
transplantation by using 2 distinct but complementary 
methods. Although endothelial cells can be obtained 
from a circulating progenitor and are capable of clonal 
expansion, these cells do not share the genotype of the 
transplanted bone marrow. We conclude that EPCs in 
circulation do not originate from the bone marrow.
Our findings contrast those of Lin and colleagues.4 
They recognized that single-cell culture would be nec-
essary to definitively address whether endothelial cells 
capable of clonal expansion derive from bone marrow. 
These methods were used in our analysis demonstrat-
ing that all clones formed from single cells were derived 
from the recipient rather than from donor bone mar-
row. Our findings were internally consistent and clear, 
and in agreement with recent evidence showing that 
endogenous neovascularization in the heart is driven by 
tissue-resident EPCs without a direct contribution from 
bone marrow cells.5 This represents a paradigm shift 
that requires a reevaluation of our approach to harness 
EPCs for therapeutic vascular regeneration.
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Figure Continued. (white arrows) and CD31-positive cells with an XY genotype (yellow arrows) are shown. Scale bar: 20 μm. *P<0.001, one-way ANOVA. Geno-
type of early-outgrowth cells, late-outgrowth endothelial cells, and vessel wall endothelial cells with (C) and without (D) CD31 expression. E, Immunofluorescence 
for CD45 (blue) and CD31 (yellow) in late-outgrowth endothelial cells. Scale bar: 50 μm. F, Short tandem repeat analysis for the sex-specific locus, amelogenin. 
The proportion of cells with XX and XY genotype was calculated from polymerase chain reaction products of 104 and 110 base pairs corresponding to the X and 
Y chromosomes, respectively. *P<0.05, one-way ANOVA. G, Images showing expansion of a colony of late-outgrowth endothelial cells from a single endothelial 
progenitor cell of recipient origin (XY genotype). Y chromosome (green), X chromosome (red), CD31 (yellow), and nuclei (DAPI, blue). Scale bar: 100 μm. DAPI 
indicates 4′,6-diamidino-2-phenylindole; and STR, short tandem repeat.
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